Literature DB >> 12593938

In vitro cellular interaction and absorption of dispersed cubic particles.

Jung Yoon Um1, Hesson Chung, Kil Soo Kim, Ick Chan Kwon, Seo Young Jeong.   

Abstract

A precursor type oily liquid formulation comprising monoolein, Pluronic F-127 and ethanol has been prepared as a carrier for lipophilic drugs. When dispersed in water, the liquid precursor formulation produces sub-micron (200-500 nm) sized lipid particles, named 'nanocubicles'. The interaction between nanocubicles and Caco-2 cell was studied, and the absorption of nanocubicles by cells was observed by various microscopic techniques. Lipid droplets were observed in cytosol after incubation with nanocubicles with time. The degree of pyrene absorption encapsulated in nanocubicles was dependent on particle size and incubation time. The amount of pyrene absorbed by Caco-2 cells was ca. 20% of total at 37 degrees C after an 8-h incubation. When nanocubicles with a bigger average particle size (ca. 600 nm) were applied, the uptake rate was reduced to 10% under identical experimental conditions. The nanocubicles were easily solubilized by bile salts to produce mixed micelles. As bile salt concentration increased, pyrene absorption into the jejunum of rat everted sac in vitro increased.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593938     DOI: 10.1016/s0378-5173(02)00673-7

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

2.  Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.

Authors:  Zhiwen Yang; Yinhe Tan; Meiwan Chen; Linghui Dian; Ziyun Shan; Xinsheng Peng; Chuanbin Wu
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

3.  Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin.

Authors:  Jie Lai; Jianming Chen; Yi Lu; Jing Sun; Fuqiang Hu; Zongning Yin; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2009-07-28       Impact factor: 3.246

Review 4.  Challenges in the Physical Characterization of Lipid Nanoparticles.

Authors:  Supandeep Singh Hallan; Maddalena Sguizzato; Elisabetta Esposito; Rita Cortesi
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

Review 5.  The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination.

Authors:  Rayen Yanara Valdivia-Olivares; Maria Rodriguez-Fernandez; María Javiera Álvarez-Figueroa; Alexis M Kalergis; José Vicente González-Aramundiz
Journal:  Vaccines (Basel)       Date:  2021-12-01

6.  Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine.

Authors:  Yuanfeng Wei; Jianjun Zhang; Yazhen Zheng; Yaxiang Gong; Meng Fu; Chengran Liu; Liang Xu; Changquan Calvin Sun; Yuan Gao; Shuai Qian
Journal:  RSC Adv       Date:  2019-02-21       Impact factor: 4.036

Review 7.  Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications.

Authors:  Hassaan Umar; Habibah A Wahab; Amirah Mohd Gazzali; Hafsa Tahir; Waqas Ahmad
Journal:  Polymers (Basel)       Date:  2022-07-31       Impact factor: 4.967

8.  Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles.

Authors:  Jie Lai; Yi Lu; Zongning Yin; Fuqiang Hu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2010-02-02

9.  Formation of Self-Assembled Liquid Crystalline Nanoparticles and Absorption Enhancement of Ω-3s by Phospholipids and Oleic Acids.

Authors:  Sang-Won Jeon; Han-Sol Jin; Young-Joon Park
Journal:  Pharmaceutics       Date:  2021-12-28       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.